NYSE:RDY Dr. Reddy's Laboratories Q2 26/27 Earnings Date & Estimates $12.92 +0.17 (+1.29%) Closing price 10/15/2026 03:59 PM EasternExtended Trading$12.92 +0.01 (+0.04%) As of 10/15/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Dr. Reddy's Laboratories is estimated to report Q2 26/27 earnings on Friday, October 23, 2026, before market opens. The conference call is scheduled for 10:00 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ2 26/27Announcement DateOctober 23, 2026TimeBefore Market OpensConference Call10:00 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Dr. Reddy's Laboratories in Q2 26/27Dr. Reddy's Laboratories is expected to post earnings of $0.0951 per share on revenue of $891.54 million. In the same quarter a year earlier Dr. Reddy's Laboratories reported $0.19 per share on revenue of $993.72 million. Dr. Reddy's Laboratories last reported on July 23, 2026, posting $0.06 per share and missing the $0.0918 consensus estimate. Dr. Reddy's Laboratories has beaten the consensus EPS estimate in 4 of its last 8 quarters.Consensus EstimatesConsensus EPS$0.0951Expected Revenue$891.54 millionPrior-Year EPS$0.19Prior-Year Revenue$993.72 millionExpected EPS Growth-49.9%Expected Revenue Growth-10.3%Recent Track RecordLast ReportedQ1 2027Last Quarter EPS$0.06 (Missed by -$0.0318)Last Quarter Revenue$850.26 millionEPS Beat Rate4 of last 8 quartersPrepare for the Q2 26/27 CallEarnings HistoryCompany ProfileQ1 2027 Earnings ReportQ4 2026 Earnings ReportQ3 2026 Earnings Report Dr. Reddy's Laboratories Q2 26/27 Earnings FAQ When does Dr. Reddy's Laboratories report Q2 26/27 earnings? Dr. Reddy's Laboratories (NYSE:RDY) is estimated to report Q2 26/27 earnings on Friday, October 23, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Dr. Reddy's Laboratories' Q2 26/27 earnings call? Dr. Reddy's Laboratories' Q2 26/27 earnings conference call is scheduled for Friday, October 23, 2026 at 10:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Dr. Reddy's Laboratories? Analysts expect Dr. Reddy's Laboratories to post earnings of $0.0951 per share for Q2 26/27. How much revenue is Dr. Reddy's Laboratories expected to report? The consensus revenue estimate for Dr. Reddy's Laboratories is $891.54 million for Q2 26/27. Dr. Reddy's Laboratories Earnings HeadlinesDr. Reddy's Laboratories (RDY) Expected to Announce Earnings on Friday1 hour ago | americanbankingnews.comDr. Reddy's Laboratories (NYSE:RDY) Stock Crosses Above 200-Day Moving Average - What's Next?October 15 at 2:41 AM | americanbankingnews.comWhy Some AI Stocks Already Surged Over 300 PercentJason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run, and Vertiv before a 1900 percent run. Now he's tracking a radical light-speed technology that could make AI 100 times faster and 100 times more energy efficient. Stocks tied to it have already climbed 133 percent, 217 percent, and 320 percent. | Brownstone Research (Ad)Analysts Offer Insights on Healthcare Companies: Zentek (OtherZTEKF) and Dr Reddy’s Laboratories (RDY)October 2, 2026 | theglobeandmail.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDYSeptember 24, 2026 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDYSeptember 22, 2026 | globenewswire.comSee More Dr. Reddy's Laboratories Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Dr. Reddy's Laboratories? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Dr. Reddy's Laboratories and other key companies, straight to your email. Email Address About Dr. Reddy's LaboratoriesDr. Reddy’s Laboratories Limited is a multinational pharmaceutical company headquartered in Hyderabad, India. Founded in 1984 by Dr. Kallam Anji Reddy, the company develops, manufactures and markets medicines intended to make healthcare more accessible. Its business includes generic pharmaceuticals, branded generics, over-the-counter products, active pharmaceutical ingredients and biosimilars. Dr. Reddy’s portfolio spans therapeutic areas such as gastrointestinal, cardiovascular, diabetes, oncology, pain management, dermatology and central nervous system treatments. The company also provides pharmaceutical development and manufacturing services. Dr. Reddy’s serves patients and healthcare providers in India, North America, Europe and other international markets, including countries in emerging markets. The company is led by Co-Chairman and Managing Director G. V. Prasad and Chief Executive Officer Erez Israeli.View Dr. Reddy's Laboratories ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Apple Cut iPhone 18 Orders; What Does It Mean For Suppliers?Domino’s Pizza: As Cheap As It Gets, Nowhere to Go But UpFastenal Flashes Bullish Signal as Uptrend Holds Despite Margin PressureASML Can’t Keep Up With AI Demand—Why That's a Good ThingCiti Stock Falls Despite Earnings Beat: What Investors Need to KnowDon’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could DeepenBig Banks Report Strong Earnings—So Why Are Shares Falling? Upcoming Earnings HDFC Bank (10/17/2026)ICICI Bank (10/17/2026)America Movil (10/20/2026)Netflix (10/20/2026)General Motors (10/20/2026)Chubb (10/20/2026)Capital One Financial (10/20/2026)Intuitive Surgical (10/20/2026)GE Aerospace (10/20/2026)3M (10/20/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
